GLUTAMATE RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;
PROCYCLIDINE;
ANTICHOLINERGIC EFFECT;
COGNITION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
HUMAN;
LEARNING;
LETTER;
MEMORY;
NERVE CELL PLASTICITY;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SCHIZOPHRENIA;
SIDE EFFECT;
Effects of oral procyclidine administration on cognitive functions in healthy subjects: Implications for schizophrenia
Zachariah E, Kumari V, Galea A, et al. Effects of oral procyclidine administration on cognitive functions in healthy subjects: Implications for schizophrenia. J Clin Psychopharmacol. 2002;22:224-226.
A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs
McDonough JH Jr, Shih TM. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol Biochem Behav. 1995;51:249-253.
[3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites
Reynolds IJ, Miller RJ. [3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites. J Pharmacol Exp Ther. 1988;247:1025-1031.
The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice
Zarnowski T, Kleinrok Z, Turski WA, et al. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice. J Neural Transm Gen Sect. 1994;97:1-12.
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5
Morris RG, Anderson E, Lynch GS, et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 1986;319:774-776.
Drugs acting at the glycine site on the NMDA receptor as cognitive enhancers in patients with Alzheimer's disease
Roesler R, Quevedo J, Walz R, et al. Drugs acting at the glycine site on the NMDA receptor as cognitive enhancers in patients with Alzheimer's disease. Neurology. 1988;50:1195.